Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Arestin in Chronic Periodontitis
NCT00668746Phase 4Completed
- Sponsor
- OraPharma
- Start
- Dec 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of minocycline in chronic periodontitis (2 arms), sponsored by OraPharma. Primary endpoint: Change in Percent of Minocycline-Resistant Bacteria Using Bacterial Culture at Day 180. Started Dec 2007; status: completed.
02
Drugs
minocycline
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT00668746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668746.